Chartwell Investment Partners, LLC Iveric Bio, Inc. Transaction History

Chartwell Investment Partners, LLC

  • $2.91 Billion
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2023

Apr 14, 2023
BUY
$18.67 - $24.56 $281,823 - $370,733
15,095 Added 39.08%
53,720 $1.31 Million
Q4 2022

Feb 15, 2023
BUY
$17.24 - $23.95 $38,031 - $52,833
2,206 Added 6.06%
38,625 $827,000
Q3 2022

Oct 27, 2022
BUY
$9.4 - $18.59 $342,338 - $677,029
36,419 New
36,419 $654,000

Others Institutions Holding ISEE

# of Institutions
7
Shares Held
250K
Call Options Held
40K
Put Options Held
0
View Full List

About IVERIC bio, Inc.

ISEE Quotes by TradingView
  • Ticker ISEE
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 118,078,000
  • Description
  • IVERIC bio, Inc., a biopharmaceutical company, discovers and develops novel treatments for retinal diseases with a focus on age-related and orphan inherited retinal diseases (IRDs). The company develops Zimura, an inhibitor of complement factor C5 comprising GATHER1, which has completed Phase 2/3 clinical trial; and GATHER2 that is in Phase 3 cl...
More about ISEE
Track This Portfolio

Track Chartwell Investment Partners, LLC Portfolio

Follow Chartwell Investment Partners, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Chartwell Investment Partners, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Chartwell Investment Partners, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email